Prevalence and risk factors of generalized anxiety disorder among adult COVID-19 survivors in Cuddalore district, Tamil Nadu
Keywords:GADs, COVID-19 survivors, Pandemic, Cuddalore
Background: The infectious disease pandemic (COVID-19) has not only affected the physical health but also the psychosocial health of the infected population by increasing anxiety and stress. Our aim of this study is to estimate the generalized anxiety disorder (GAD) among the COVID-19 survivors in Cuddalore district, Tamil Nadu.
Methods: A community -based descriptive cross-sectional study was carried out among 330 COVID-19 survivors in Cuddalore district, Tamil Nadu during December 2021 to May 2022. A predesigned and pretested, semi-structured proforma was used to collect data about the basic socio-demographic variables and COVID-19 infection related variables. A standardised 7 item GAD scale (GAD 7) was used for screening symptoms of anxiety. The presence of symptoms of anxiety was defined by a GAD 7 score of 8 and above. A p<0.05 was considered statistically significant.
Results: Out of 330 study participants, 15.8% of them had symptoms of anxiety with GAD 7 score of >8. We found significant level of anxiety with age, female gender, marital status, socio-economic status, and presence of co-morbidity, Similarly, COVID-19 related factors like duration of hospital stay, family members either being affected or died due to COVID-19 infection were significantly associated with high level of anxiety.
Conclusions: During this COVID-19 pandemic, the symptoms GAD was much higher among the COVID-19 survivors. A timely diagnosis and management are essential, by creating awareness at all levels of health care personal in the health system.
WHO Director-General’s opening remarks at the media briefing on COVID-19. 2020. Available at: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed on 15 June 2022.
India: WHO Coronavirus Disease (COVID-19) Dashboard with Vaccination Data. WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. Available at: https://covid19.who.int/region/searo/country/in. Accessed on 15 June 2022.
Asim M, Van Teijlingen E, Sathian B. Coronavirus Disease (COVID-19) and the risk of Post-Traumatic Stress Disorder: A mental health concern in Nepal. Nepal J Epidemiol. 2020;10(2):841-4.
Munir S, Takov V. Generalized Anxiety Disorder. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. Available from: http://www.ncbi.nlm.nih.gov/books/NBK441870/. Accessed on 8 October 2022.
Santomauro DF, Mantilla Herrera AM, Shadid J, Zheng P, Ashbaugh C, Pigott DM, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet. 2021;398(10312):1700-12.
Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiat. 2021;8(2):130-40.
Forte G, Favieri F, Tambelli R, Casagrande M. COVID-19 Pandemic in the Italian Population: Validation of a Post-Traumatic Stress Disorder Questionnaire and Prevalence of PTSD Symptomatology. Int J Environ Res Public Health. 2020;17(11):4151.
Silva MT, Caicedo Roa M, Martins SS, Da Silva ATC, Galvao TF. Generalized anxiety disorder and associated factors in adults in the Amazon, Brazil: A population-based study. J Affect Disord. 2018;236:180-6.
Wilson W, Raj JP, Rao S, Ghiya M, Nedungalaparambil NM, Mundra H, et al. Prevalence and Predictors of Stress, anxiety, and Depression among Healthcare Workers Managing COVID-19 Pandemic in India: A Nationwide Observational Study. Indian J Psychol Med. 2020;42(4):353-8.
Devi D, Monica V, Santhosh R, Raghavan V, Poornachandrika P. Psychological morbidity among post-COVID-19 patients: A cross-sectional study from Chennai, South India. Indian J Ment Health Neurosci. 2021;4(1):10-7.
Pashazadeh Kan F, Raoofi S, Rafiei S, Khani S, Hosseinifard H, Tajik F, et al. A systematic review of the prevalence of anxiety among the general population during the COVID-19 pandemic. J Affect Disord. 2021;293:391-8.
Manjunatha N, Jayasankar P, Suhas S, Rao G, Gopalkrishna G, Varghese M, et al. Prevalence and its correlates of anxiety disorders from India’s National Mental Health Survey 2016. Ind J Psychiat. 2022;64(2):138.
Imran J, Nasa P, Alexander L, Upadhyay S, Alanduru V. Psychological distress among survivors of moderate-to-critical COVID-19 illness: A multicentric prospective cross-sectional study. Ind J Psychiatr. 2021;63(3):285-9.
Chen H, Gao J, Dai J, Mao Y, Wang Y, Chen S, et al. Generalized anxiety disorder and resilience during the COVID-19 pandemic: evidence from China during the early rapid outbreak. BMC Public Health. 2021;21(1):1830.
Da Silva ML, Rocha RSB, Buheji M, Jahrami H, Cunha K da C. A systematic review of the prevalence of anxiety symptoms during coronavirus epidemics. J Health Psychol. 2021;26(1):115-25.
American Psychiatric Association, American Psychiatric Association, editors. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, D.C: American Psychiatric Association. 2013.
Luo Z, Li Y, Hou Y, Liu X, Jiang J, Wang Y, et al. Gender-specific prevalence and associated factors of major depressive disorder and generalized anxiety disorder in a Chinese rural population: the Henan rural cohort study. BMC Public Health. 2019;19(1):1744.
Ruscio AM, Hallion LS, Lim CCW, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, et al. Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder Across the Globe. JAMA Psychiatr. 2017;74(5):465-75.
Preti A, Demontis R, Cossu G, Kalcev G, Cabras F, Moro MF, et al. The lifetime prevalence and impact of generalized anxiety disorders in an epidemiologic Italian National Survey carried out by clinicians by means of semi-structured interviews. BMC Psychiatr. 2021;21(1):48.
Psychological health, sleep quality, and coping styles to stress facing the COVID-19 in Wuhan, China | Translational Psychiatry. Available at: https://www.nature.com/articles/s41398-020-00913-3. Accessed on 11 October 2022.
Frontiers, Psychological Impact and Associated Factors During the Initial Stage of the Coronavirus (COVID-19) Pandemic Among the General Population in Spain. Available at: https://www.frontiersin.org/articles/10.3389/fpsyg.2020.01540/full. Accessed on 11 October 2022.
Lei L, Huang X, Zhang S, Yang J, Yang L, Xu M. Comparison of Prevalence and Associated Factors of Anxiety and Depression Among People Affected by versus People Unaffected by Quarantine During the COVID-19 Epidemic in Southwestern China. Med Sci Monit. 2020. Available at: https://medscimonit. com/abstract/index/idArt/924609. Accessed on 11 October 2022.
Zhao H, He X, Fan G, Li L, Huang Q, Qiu Q, et al. COVID-19 infection outbreak increases anxiety level of general public in China: involved mechanisms and influencing factors. J Affect Disord. 2020;276:446-52.
Gao J, Zheng P, Jia Y, Chen H, Mao Y, Chen S, et al. Mental health problems and social media exposure during COVID-19 outbreak. PLOS ONE 2020;15(4):e0231924.
Alkhamees AA, Alrashed SA, Alzunaydi AA, Almohimeed AS, Aljohani MS. The psychological impact of COVID-19 pandemic on the general population of Saudi Arabia. Compr Psychiatr. 2020;102:152192.
Guo Q, Zheng Y, Shi J, Wang J, Li G, Li C, et al. Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study. Brain Behav Immun. 2020;88:17-27.
Newby JM, O’Moore K, Tang S, Christensen H, Faasse K. Acute mental health responses during the COVID-19 pandemic in Australia. PLOS ONE. 2020;15(7):e0236562.
Risk factors for psychological distress during the COVID‐19 pandemic in Israel: Loneliness, age, gender, and health status play an important role-Horesh-2020-Bri J Heal Psychol- Wiley Online Library. Available at: https://bpspsychub. onlinelibrary.wiley.com/doi/10.1111/bjhp.12455. Accessed on 11 October 2022.
Da Silva ML. A systematic review of the prevalence of anxiety symptoms during coronavirus epidemics. J Health Psychol. 2021;26(1):115-25.